GlassScriptPhysician profile
Casandra Campion
NPI 1407620594
$3,647.57
in general payments reported to CMS, 2019-2025
15 companies · $574 in 2025
The $574 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,373 · 2024: $1,700 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,267 · Travel and Lodging: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,267.42 |
| Travel and Lodging | $1,380.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,213.49 | 2023 | Intracept |
| Boston Scientific Corporation | $888.13 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbvie INC. | $530.02 | 2024-2025 | |
| Spr Therapeutics, INC | $212.43 | 2024-2025 | Sprint Pns System |
| Nalu Medical, INC. | $119.92 | 2024 | Nalu Neurostimulation System |
| Lilly USA, LLC | $118.64 | 2024 | Emgality |
| International Rehabilitative Sciences, INC | $116.46 | 2023-2025 | Rs 4i Plus Sequential Stimulator, Rs-4i Plus With Intersperse |
| Pfizer INC. | $82.93 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $82.45 | 2024-2025 | |
| Si-Bone, INC. | $74.02 | 2025 | |
| Ibsa Pharma INC. | $63.81 | 2024 | Licart, Tirosint, Flector |
| Scilex Pharmaceuticals INC. | $57.53 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $44.93 | 2024 | Exparel, Zilretta, Iovera |
| Saluda Medical Americas, INC. | $22.83 | 2025 | Evoke |
| Ipsen Biopharmaceuticals, INC | $19.98 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casandra Campion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.